|
内镜下治疗食管胃底静脉曲张发生短期再出血危险因素分析
|
Abstract:
目的:探讨分析内镜下治疗食管胃底静脉曲张发生短期再出血危险因素。方法:回顾性分析2019年5月至2024年10月西宁市第二人民医院消化内科收治的行手术治疗的肝硬化伴食管胃底静脉曲张患者临床资料,将患者分为出血和未出血两组,对两组患者的再出血率进行分析,并应用Logistic回归比例风险模型进行临床预后的多因素分析。结果:共纳人94例患者,其中男性58例,女性36例,平均年龄52.03 ± 10.89岁,再出血患者16例,治疗好转78人,其中性别、年龄,病程,PT,TP,WBC,RBC,PLT,Hb,门静脉内直径等因素无关,差异无统计学意义(P > 0.05),白蛋白(OR = 0.845, 95% CI: 0.729~0.980)、静脉曲张程度(OR = 2.787, 95% CI: 1.031~7.530)、手术方式(OR = 19.090, 95% CI: 2.728~133.582)可以作为影响术后再出血独立危险因素,结论:内镜下食管胃曲张静脉断流术(ESVD)、静脉曲张严重程度和白蛋白水平对术后再出血发生率影响明显,术前合理的选择手术方式,纠正白蛋白水平可以改善患者预后,降低再出血发生率。
Objective: To explore and analyze the risk factors of short-term rebleeding after endoscopic treatment of esophageal and gastric varices. Methods: the clinical data of cirrhotic patients with esophageal and gastric varices who underwent surgery in the Department of Gastroenterology of Xining Second People’s Hospital from April 2018 to December 2024 were retrospectively analyzed. The patients were divided into bleeding and non bleeding groups. The rebleeding rate of the two groups was analyzed, and the logistic regression proportional hazards model was applied to analyze the multivariate analysis of clinical prognosis. Results: a total of 94 patients were enrolled, including 58 males and 36 females, with an average age of 52.03 ± 10.89 years. There were 16 patients with rebleeding, and 78 patients improved after treatment, including gender, age, course of disease, PT, TP, WBC, RBC, PLT, Hb, there was no significant difference in the internal diameter of portal vein and other factors (P > 0.05). Albumin (or = 0.845, 95% CI: 0.729~0.980), the degree of varicose vein (or = 2.787, 95% CI: 1.031~7.530), and surgical method (or = 19.090, 95% CI: 2.728~133.582) can be used as independent risk factors for postoperative rebleeding. Conclusion: ESVD of esophageal vein, the severity of varices and albumin level have a significant impact on the incidence of postoperative rebleeding. Reasonable preoperative choice of surgical method and correction of albumin level can improve the prognosis of patients and reduce the incidence of rebleeding rate.
[1] | 赵爽, 朱玉轩, 刘越, 等. 肝硬化食管胃静脉曲张二级预防患者内镜治疗后再出血的影响因素分析[J]. 临床肝胆病杂志, 2024, 40(12): 2430-2440. |
[2] | 吕勇, 韩国宏, 樊代明. 肝硬化急性静脉曲张出血的治疗现状[J]. 中华肝脏病杂志, 2024, 32(11): 1037-1041. |
[3] | 马弛, 黄伟俊, 钟敏莹. 影像学预测肝硬化患者食管胃静脉曲张及出血研究进展[J]. 中国医学影像技术, 2024, 40(12): 1965-1968. |
[4] | 李佳鑫, 李贞娟, 张慧敏, 等. 门静脉血栓与非急诊内镜下治疗食管胃静脉曲张术后再出血的关联[J]. 中华医学杂志, 2024(9): 682-689. |
[5] | 王省, 胡兵, 李异玲, 等. 中国门静脉高压食管胃静脉曲张内镜治疗现状调研分析[J]. 中华消化内镜杂志, 2024, 41(1): 43-51. |
[6] | 韦炜, 洪依萍, 蔡建庭. 食管胃静脉曲张出血内镜下二级预防术后使用生长抑素预防再出血的研究[J]. 胃肠病学, 2023, 28(10): 622-625. |
[7] | 耿楠, 孔明, 陈煜, 等. 肝硬化门静脉高压与营养不良的关系[J]. 临床肝胆病杂志, 2023, 39(9): 2205-2209. |
[8] | 周丽丽, 张春清. 门静脉高压侧支循环与食管胃静脉曲张的关系[J]. 临床肝胆病杂志, 2023, 39(9): 2210-2216. |
[9] | 董雯迪, 杨佳妮, 朱婕, 等. 肝硬化门静脉血栓形成患者并发消化道出血的相关因素研究[J]. 中国全科医学, 2024, 27(5): 552-556. |
[10] | 中华医学会超声医学分会, 中国门静脉高压联盟(CHESS). 中国超声弹性成像技术诊断肝硬化门静脉高压专家共识(2023版) [J]. 中华医学杂志, 2023(32): 2480-2494. |
[11] | 向童, 罗薛峰, 杨丽. 肝硬化食管胃静脉曲张出血的治疗策略[J]. 解放军医学杂志, 2023, 48(10): 1115-1121. |
[12] | 张瑞, 马丽黎. 门静脉血栓影响肝硬化进程与食管胃静脉曲张处理[J]. 中国实用内科杂志, 2022, 42(10): 820-823+830. |
[13] | 蒋式骊, 刘平. 肝硬化中西医结合治疗的研究进展[J]. 临床肝胆病杂志, 2022, 38(9): 1953-1955. |
[14] | 张晓丰, 陈金军. 肝硬化门静脉高压的无创筛查管理[J]. 临床肝胆病杂志, 2022, 38(6): 1220-1223. |
[15] | 王艳玲, 韩军, 马雪梅, 等. 食管胃静脉曲张内镜下一级预防治疗对出血率的影响及其相关因素[J]. 中华肝脏病杂志, 2022, 30(4): 407-412. |